It is disingenuous because the Cochlear journey from infancy to success is not even similar to PAA so it is not a comparison.
I agree "time will tell" and I hope for all of us it tells how we want. I am merely pointing out that at this present time what time is telling and nothing more.
To correct you in the Share Market the Market is God as that is what ends up being failure or success. If the entire market abandons PAA then who funds the research.
On a separate issue I have always wondered why the turn over of epichem never seems to impact on an increase to the market cap either?
- Forums
- ASX - By Stock
- Ann: PharmAust Expands Lymphoma Canine Trial to the USA
It is disingenuous because the Cochlear journey from infancy to...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.015(7.50%) |
Mkt cap ! $90.96M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 18.5¢ | $106.2K | 550.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 714303 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 26750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 714303 | 0.185 |
8 | 384080 | 0.180 |
5 | 151797 | 0.175 |
7 | 208030 | 0.170 |
1 | 60000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 26750 | 1 |
0.195 | 108645 | 5 |
0.205 | 106604 | 5 |
0.210 | 148876 | 3 |
0.215 | 154400 | 2 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online